Healthcare -
Biotechnology - NASDAQ - US
$ 14.69
3.89 %
$ 1.49 B
Market Cap
-4.1
P/E
DYN - OTHER CURRENT LIABILITIES
Other Current Liabilities DYN - Dyne Therapeutics, Inc.
23.4 M
LAST VALUE
17.75%
2 YEAR CAGR
161.14%
5 YEAR CAGR
16.71%
10 YEAR CAGR